Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,737 | 105 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $510.51 | 36 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $202.79 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $159.81 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $139.73 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $96.49 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $92.44 | 6 | $0 (2024) |
| Gilead Sciences, Inc. | $72.03 | 6 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $69.64 | 4 | $0 (2017) |
| QOL Medical, LLC | $48.48 | 3 | $0 (2024) |
| Boston Scientific Corporation | $40.21 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $542.80 | 26 | Takeda Pharmaceuticals U.S.A., Inc. ($155.56) |
| 2023 | $142.09 | 9 | ABBVIE INC. ($77.95) |
| 2022 | $209.97 | 9 | E.R. Squibb & Sons, L.L.C. ($96.49) |
| 2021 | $44.34 | 3 | AbbVie Inc. ($29.14) |
| 2020 | $52.35 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($14.56) |
| 2019 | $73.83 | 6 | AbbVie, Inc. ($23.55) |
| 2018 | $278.94 | 22 | AbbVie, Inc. ($121.25) |
| 2017 | $392.68 | 26 | AbbVie, Inc. ($211.35) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 5 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/30/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Immunology | ||||||
| 01/23/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Immunology | ||||||
| 01/09/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Immunology | ||||||
| 01/03/2017 | Valeant Pharmaceuticals North America LLC | XIFAXANIBSD (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 612 | 649 | $286,080 | $66,337 |
| 2022 | 11 | 546 | 592 | $244,716 | $61,115 |
| 2021 | 11 | 646 | 731 | $226,856 | $60,875 |
| 2020 | 12 | 647 | 763 | $238,765 | $61,884 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 96 | 97 | $41,710 | $14,290 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 88 | $24,992 | $7,622 | 30.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 94 | 94 | $55,160 | $7,300 | 13.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $21,170 | $7,177 | 33.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 24 | 24 | $25,008 | $5,333 | 21.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 50 | 50 | $50,530 | $5,033 | 10.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 32 | 32 | $24,643 | $4,588 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 60 | $12,000 | $4,401 | 36.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 54 | $8,799 | $3,607 | 41.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 50 | 59 | $5,859 | $2,455 | 41.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $6,111 | $2,273 | 37.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 12 | $10,098 | $2,259 | 22.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 81 | 85 | $36,550 | $14,313 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $17,755 | $6,441 | 36.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 56 | 56 | $16,296 | $6,202 | 38.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 43 | 43 | $45,155 | $6,004 | 13.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 67 | 68 | $45,435 | $5,828 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 76 | $15,200 | $5,077 | 33.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 20 | 20 | $22,830 | $4,238 | 18.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 26 | 27 | $20,207 | $3,717 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 36 | $10,224 | $3,421 | 33.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 56 | $8,680 | $3,407 | 39.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 66 | 76 | $6,384 | $2,468 | 38.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 152 | 153 | $44,523 | $17,616 | 39.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 154 | 209 | $17,556 | $6,858 | 39.1% |
About Dr. Jamie Kasper, M.D
Dr. Jamie Kasper, M.D is a Gastroenterology healthcare provider based in Bala Cynwyd, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861455537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamie Kasper, M.D has received a total of $1,737 in payments from pharmaceutical and medical device companies, with $542.80 received in 2024. These payments were reported across 105 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,737).
As a Medicare-enrolled provider, Kasper has provided services to 2,451 Medicare beneficiaries, totaling 2,735 services with total Medicare billing of $250,211. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Bala Cynwyd, PA
- Active Since 04/11/2006
- Last Updated 10/01/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1861455537
Products in Payments
- Humira (Biological) $236.42
- ENTYVIO (Biological) $189.13
- DUPIXENT (Biological) $139.73
- STELARA (Biological) $123.30
- Mavyret (Drug) $96.34
- LINZESS (Drug) $95.17
- XIFAXAN (Drug) $73.67
- TRULANCE (Drug) $57.43
- SUCRAID (Drug) $48.48
- WATCHMAN (Device) $40.21
- Trulance (Drug) $38.13
- OMVOH (Drug) $37.33
- SKYRIZI (Biological) $32.88
- CONMED GENERATORS (Device) $31.17
- DIFICID (Drug) $25.05
- CLENPIQ (Drug) $24.53
- Movantik (Drug) $24.03
- Creon (Drug) $23.39
- TREMFYA (Drug) $21.45
- MOVIPREP (Drug) $19.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bala Cynwyd
Alexander Harmatz, M.d, M.D
Gastroenterology — Payments: $18,624
Anthony Rosa, M.d, M.D
Gastroenterology — Payments: $12,302
Raynard Cheung, M.d, M.D
Gastroenterology — Payments: $11,456
Jeffrey Pilchman, M.d, M.D
Gastroenterology — Payments: $6,611
Gregory Schapiro, M.d, M.D
Gastroenterology — Payments: $5,597
Jenifer Lehrer, M.d, M.D
Gastroenterology — Payments: $5,549